Interestingly, previous reports showed significantly increased expression of LOX mRNA in prostate carcinomas compared to nodular prostate hyperplasia [7], whereas stronger LOX expression was also observed in other solid malignancies [27, 60, 61]. Here, LOX is linked to prostate carcinoma.